TAK-071 Scopolamine-Induced Cognitive Impairment Study
Status:
Terminated
Trial end date:
2017-08-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect of a single oral dose of TAK-071 on the
attenuation of cognitive deficit induced by scopolamine as measured by Groton Maze Learning
Test (GMLT) (total number of errors).